Quinazoline derivate and use thereof as apoptosis inhibitor

The present invention relates to the new use and target of a compound of formula I such as terazosin. In particular, the present invention relates to the use of the compound of formula I in the preparation of drugs used as an apoptosis inhibitor or drugs for treating and/or preventing sepsis and the complications thereof. The present invention provides a new method and direction for inhibiting apoptosis and treating and/or preventing sepsis and the complications thereof.